The Saudi
Genitourinary (GU)
Working Group
Prostate Cancer
This platform was created as a comprehensive resource for clinicians managing urothelial and prostate cancers, offering access to clinical protocols, molecular updates, treatment algorithms, and educational content curated by experts from across the Kingdom.
About us
Our services
WHAT WE DO?
Empowering healthcare providers with knowledge, collaboration, and education to improve care and outcomes for patients with GU cancers worldwide.
Seminars
Focused educational sessions designed to deepen understanding through expert presentations.
Informative Conferences
Professional gatherings that bring industry leaders together to present ideas, research, and trends.
Insightful Podcasts
Audio programs featuring conversations, expert interviews, and discussions providing valuable perspectives.
Compelling Testimonials
Real experiences from oncology specialists highlighting the impact and success of localized initiatives.
engaging webinars
Live online sessions where experts share clinical knowledge and interactive discussions with participants.
Connecting Experts
Opportunities that bring professionals, thought leaders, and specialists together to collaborate.
informative videos
Short, engaging visual content explaining clinical algorithms, surgical techniques, and molecular updates.
Our core focus
Educational content
Educational content
healthcare professionals
Prostate Cancer
Prostate cancer stands as the second most prevalent cancer affecting males worldwide.
Read moreBladder cancer
Bladder cancer has moved up from the 10th to the 9th most diagnosed cancer worldwide, with both incidence and mortality rates increasing.
Read moreUrothelial Cancer
Urothelial carcinoma, also known as transitional cell carcinoma (TCC), primarily affects the bladder but can also occur in the upper urinary tract.
Read more
- Our initiatives
focus on
-
Disseminating the latest molecular and clinical insights in urothelial and prostate cancer.
-
Promoting multidisciplinary case discussions and expert consensus on best practices.
-
Developing localized clinical guidelines and decision-support tools.
-
Supporting collaborative research to address region-specific challenges and patient needs.
